TAYEBATI, Seyed Khosrow
 Distribuzione geografica
Continente #
NA - Nord America 26.662
EU - Europa 13.488
AS - Asia 13.384
SA - Sud America 1.399
Continente sconosciuto - Info sul continente non disponibili 925
AF - Africa 356
OC - Oceania 42
Totale 56.256
Nazione #
US - Stati Uniti d'America 25.553
CN - Cina 5.220
SG - Singapore 3.331
IT - Italia 2.972
RU - Federazione Russa 2.916
HK - Hong Kong 2.089
PL - Polonia 1.772
BR - Brasile 1.158
FR - Francia 1.072
UA - Ucraina 1.051
DE - Germania 1.048
VN - Vietnam 874
CA - Canada 853
SE - Svezia 776
GB - Regno Unito 630
FI - Finlandia 511
TR - Turchia 441
KR - Corea 425
IE - Irlanda 255
ZA - Sudafrica 233
IN - India 215
BD - Bangladesh 165
MX - Messico 134
NL - Olanda 128
AR - Argentina 75
IQ - Iraq 70
JP - Giappone 70
IR - Iran 65
PK - Pakistan 62
CH - Svizzera 56
CZ - Repubblica Ceca 55
ID - Indonesia 54
EU - Europa 44
ES - Italia 42
EC - Ecuador 38
AU - Australia 36
MY - Malesia 35
CO - Colombia 34
BE - Belgio 32
GR - Grecia 32
MA - Marocco 31
SA - Arabia Saudita 29
UZ - Uzbekistan 29
JM - Giamaica 28
AE - Emirati Arabi Uniti 25
CR - Costa Rica 25
PE - Perù 24
TW - Taiwan 23
LT - Lituania 22
AT - Austria 21
CL - Cile 21
VE - Venezuela 21
PH - Filippine 20
EG - Egitto 18
TH - Thailandia 17
NP - Nepal 16
RO - Romania 16
IL - Israele 14
AZ - Azerbaigian 13
DZ - Algeria 13
PY - Paraguay 13
TN - Tunisia 13
TT - Trinidad e Tobago 13
JO - Giordania 12
AL - Albania 11
EE - Estonia 10
KZ - Kazakistan 10
UY - Uruguay 10
DK - Danimarca 9
HN - Honduras 9
HU - Ungheria 9
NG - Nigeria 8
PA - Panama 8
GH - Ghana 7
KE - Kenya 7
KG - Kirghizistan 7
LB - Libano 7
NI - Nicaragua 7
NO - Norvegia 7
RS - Serbia 7
GT - Guatemala 6
PT - Portogallo 6
DO - Repubblica Dominicana 5
GE - Georgia 5
LA - Repubblica Popolare Democratica del Laos 5
NZ - Nuova Zelanda 5
OM - Oman 5
BO - Bolivia 4
GA - Gabon 4
KH - Cambogia 4
LV - Lettonia 4
PR - Porto Rico 4
QA - Qatar 4
SY - Repubblica araba siriana 4
AM - Armenia 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
CM - Camerun 3
CY - Cipro 3
Totale 55.315
Città #
Jacksonville 2.200
Ashburn 2.084
Hong Kong 2.061
San Jose 1.789
Council Bluffs 1.606
Warsaw 1.572
Singapore 1.514
Fairfield 1.323
Chandler 1.230
Woodbridge 1.163
Boardman 1.015
Houston 916
Wilmington 787
Beijing 693
Ann Arbor 626
Seattle 598
Nanjing 585
Toronto 579
The Dalles 497
Cambridge 448
Los Angeles 419
New York 375
Seoul 373
Tongling 348
Istanbul 344
Princeton 339
Lawrence 336
San Mateo 331
Shanghai 312
Columbus 308
Lauterbourg 301
Camerino 298
Helsinki 290
Dallas 274
Ho Chi Minh City 273
Ogden 271
Dearborn 240
Dublin 237
St Louis 235
Nanchang 226
Johannesburg 206
Santa Clara 203
Centro 188
Guangzhou 182
Milan 182
Buffalo 180
Dong Ket 160
Moscow 160
Trieste 156
Hanoi 151
Rome 148
Zhengzhou 147
Kraków 146
Shenyang 135
Chicago 134
Jiaxing 134
Kunming 116
Lachine 112
London 111
São Paulo 111
Orem 110
Phoenix 110
Düsseldorf 107
Munich 101
Tianjin 97
Hebei 90
Philadelphia 89
Redondo Beach 89
Bremen 76
Wuhan 76
Frankfurt am Main 71
Atlanta 69
Redwood City 69
Changsha 66
Hangzhou 65
Denver 63
Chennai 60
Montreal 60
Tokyo 60
San Diego 59
Jinan 54
Mexico City 54
Vinnytsia 54
Rio de Janeiro 52
Brooklyn 50
Basingstoke 45
Falls Church 45
Kocaeli 44
Hefei 43
Norwalk 43
Shenzhen 42
Manchester 41
Naples 39
Detroit 38
San Francisco 38
Stockholm 38
Lanzhou 37
Mumbai 36
Boston 35
Somerdale 35
Totale 34.928
Nome #
Modified expression of peripheral blood lymphocyte muscarinic cholinergic receptors in asthmatic children. 1.211
Effetti neuroprotettivi del Nerve Growth Factor somministrato come collirio in bambini e giovani adulti con deficits visivi indotti da gliomi delle vie ottiche 805
A multidisciplinary approach to study the brain injury in Diet-Induced (DIO) rats 527
Metabolic effects of tart Cherries Supplementation in an animal model of obesity 485
Anatomia del Gray, I Fondamenti 458
Neurological Disorder, Stroke: Relevance of Preclinical Studies 415
Choline and Choline alphoscerate Do Not Modulate Inflammatory Processes in the Rat Brain 380
Effects of Tart Cherry supplementation in Diet-Induced Obesity (DIO) rats. 372
Obesity-related nervous system injury: preliminary evidences in diet induced obesity (DIO) rats. 366
Telerehabilitation: Review of the State-of-the-Art and Areas of Application 358
Effect of treatment with the antioxidant alpha-lipoic (thioctic) acid on heart and kidney microvasculature in spontaneously hypertensive rats 347
Process mining case study approach: Extraction of unconventional event logs to improve performance in Hospital Information Systems (HIS) 337
EXPRESSION OF SINAPTO-VESICULAR PROTEINS IN BRAIN AREAS OF AN ANIMAL MODEL OF METABOLIC SYNDROME 330
Obesity affects central nervous system: a multidisciplinary study in Diet-Induced Obesity (DIO) rats 330
Frontiers in Molecular Biosciences 328
Identification of World Health Organisation ship's medicine chest contents by Anatomical Therapeutic Chemical (ATC) classification codes. 327
Neuroinflammatory Markers in Spontaneously Hypertensive Rat Brain: An Immunohistochemical Study 324
THE OBESE ZUCKER RATS: AN IN VIVO MODEL FOR STUDYING THE LIVER CARBONIC ANHYDRASE CAVII BIOLOGICAL ROLE 307
Brain alterations in high fat diet induced obesity: Effects of tart cherry seeds and juice 282
Brain Activity of Thioctic Acid Enantiomers: In Vitro and in Vivo Studies in an Animal Model of Cerebrovascular Injury 277
Comparative analysis of the medicinal compounds of the ship's "medicine chests" in European Union maritime countries. Need for improvement and harmonization 269
ACETYLCHOLINE PRECURSORS ATTENUATE NEUROINFLAMMATION IN LPS-STIMULATED BV2 CELLS 267
Guida alla Farmacia di Bordo 262
Astrogliosis in the brain of obese Zucker rat: a model of metabolic syndrome. 262
NEUROPLASTICITY OF ENTERIC NERVOUS SYSTEM IN ANIMAL MODEL OF OBESITY 261
Adrenergic receptor subtypes in human peripheral blood lymphocytes. 261
Hypotensive effect of intravenous injection of tachykinins in conscious, freely moving spontaneously hypertensive and Wistar Kyoto rats. 257
Editorial Board of Neurosurgery Cases and Reviews 257
Comparative machine-learning approach: A follow-up study on type 2 diabetes predictions by cross-validation methods 257
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications. 255
Effects of acetylcholine precursors on inflammation in rat brain 253
OBESITY-RELATED CEREBROVASCULAR INJURY IN OBESE ZUCKER RATS 252
Report on market analysis and preventions need to provide medications for rural patients of Italy using ICT technologies 250
Age-related changes of dopamine receptors in the rat hippocampus: a light microscope autoradiography study. 248
PROTECTIVE ACITIVITY OF THE CHOLINE CONTAINING PHOSPHOLIPID CHOLINE ALPHOSCERATE, ON CEREBROVASCULAR TREE OF SPONTANEOUSLY HYPERTENSIVE RATS 247
Cerebrovascular and blood-brain barrier morphology in spontaneously hypertensive rats: effect of treatment with choline alphoscerate. 242
A novel clinical syndrome revealing a deficiency of the muscarinic M3 receptor. 238
THE PHARMACIST KNOWLEDGE AND COMPUTER SKILLS TOWARDS E-HEALTH. RESULTS OF A SURVEY AMONG ITALIAN COMMUNITY PHARMACISTS 238
Effects of Prunus cerasus L. Seeds and Juice on Liver Steatosis in an Animal Model of Diet-Induced Obesity 237
Vesicular acetylcholine transporter (VAChT) in the brain of spontaneously hypertensive rats (SHR): effect of treatment with an acetylcholinesterase inhibitor 236
(Neuro)transmitter systems in circulating immune cells: a target of immunopharmacological interventions? 235
Discovery of Highly Selective Imidazoline Receptor Ligands 231
ACTIVITY OF THIOCTIC ACID ENANTIOMERS ON SPINAL CORD CHANGES CONSEQUENT TO PERIPHERAL NERVE INJURY 228
Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes 226
Intranasal Drug Delivery to the Central Nervous System: Present Status and Future Outlook. 224
Age-related changes in the brain of obese Zucker rat: Morphological and immunochemical analysis. 223
Policies and challenges on the distribution of specialists and subspecialists in rural areas of Iran 223
Obesity-related blood brain barrier changes in obese Zucker rats 221
Synthesis and muscarinic properties of (1S*,3R*,5R*)-trimethyl(1-methyl-6-oxabicyclo[3.1.0]hex-3-yl)methyl ammonium iodide 220
Vesicular monoamine transporter 1 mediates dopamine secretion in rat proximal tubular cells 219
Brain cholinergic dysfunction in obese Zucker LEPR(fa/fa) rats 219
Ein neues klinisches Syndrom bedingt durch eine Defizienz des muskarinergen M3-Rezeptors: Trias aus bilateraler Mydriasis, Blasenentleerungsstörung und schlankem Habitus 217
ACTIVITY OF CHOLINE ALPHOSCERATE ON CEREBROVASCULAR MORPHOLOGY AND INFLAMMATORY MARKERS IN SPONTANEOUSLY HYPERTENSIVE RATS 216
EFFECTS OF CHOLINE-ALPHOSCERATE AND THIOCTIC ACID ON THE BRAIN OF HYPERTENSIVE RATS 215
Anti-Inflammatory and Antioxidant Properties of Tart Cherry Consumption in the Heart of Obese Rats 213
Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission 211
Use of frozen sections for the pharmacological characterization of compounds active on neurotransmitter receptors 208
Age-related changes of muscarinic cholinergic receptor subtypes in the striatum of Fisher 344 rats. 208
Heart morphology in Zucker-obese rats 207
Dementias and cognitive disorders: New insights and approaches 206
Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes 203
Cardiovascular changes related to metabolic syndrome: Evidence in obese zucker rats 203
Occupancy by oral administration of nicardipine of L-type calcium channels in rat brain 202
Localization of the m5 muscarinic cholinergic receptor in rat circle of Willis and pial arteries 201
ALLA SCOPERTA DEL RUOLO DELL’INVECCHIAMENTO E DEL SESSO NEI PROCESSI DEGENERATIVI FISIOLOGICI E PATOLOGICI DEI NERVI PERIFERICI. 198
Phospholipid and Lipid Derivatives as Potential Neuroprotective Compounds 198
Changes in muscarinic cholinergic receptor expression in human peripheral blood lymphocytes in allergic rhinitis patients. 197
Effects of cholinergic enhancing drugs on cholinergic transporters in the brain and peripheral blood lymphocytes of spontaneously hypertensive rats. 197
Muscarinic Thioligands with Cyclopentane Nucleus 197
Dopamine and vascular dynamics control: present status and future perspectives. 195
A2A Adenosine Receptor Antagonists: Are Triazolotriazine and Purine Scaffolds Interchangeable? 194
Synthesis, Absolute Configuration, and Biological Profile of the Enantiomers of trans-[2-(2,6-Dimethoxypheoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (Mephendioxan), a Potent Competitive alpha 1A-Adrenoreceptor Antagonist 193
Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction. 193
Age-related Changes in the Density of Muscarinic Cholinergic M1 and M2 Receptor Subtypes in Pyramidal Neurons or the rat Hippocampus 192
Modulation Of Monoaminergic Transporters By Choline-Containing Phospholipids In Rat Brain. 192
Glial fibrillary acidic protein and vimentin expression is regulated by glucocorticoids and neurotrophic factors in primary rat astroglial cultures 191
Obesity and Metabolic Syndrome Affects the Cholinergic Transmission and Cognitive Functions 191
Postnatal development of dopamine D1-like and D2-like receptors in the rat kidney: a radioligand binding study 190
Influence of dermal exposure to the pyrethroid insecticide deltamethrin on rat brain microanatomy and cholinergic/dopaminergic neurochemistry. 190
Animal models of cognitive dysfunction. 189
Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study 188
Evaluation of an Agonist Index: Affinity Ratio for Compounds Active on Muscarinic Cholinergic M2 Receptors 188
TREATMENT WITH A CHOLINERGIC PRECURSOR IN AN ANIMAL MODEL OF CEREBROVASCULAR DISEASE: INSIGHTS INTO MECHANISMS OF NEUROPROTECTIVE ACTIVITY 188
Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands 188
Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. 187
Spontaneously hypertensive rat as a model of vascular brain disorder: Microanatomy, neurochemistry and behavior. 187
Potential dopamine-1 receptor stimulation in hypertension management. 186
Member of SCIENTIFIC ADVISORY BOARD of 9th International Congress on Vascular Dementia 186
ALPHA1-ADRENERGIC RECEPTOR SUBTYPES HUMAN PERIPHERAL BLOOD LYMPHOCYTES 184
BRAIN MORPHOLOGICAL ANALYSIS OF OBESE ZUCKER RAT: MODEL OF METABOLIC SYNDROME. 184
Batten disease through different in vivo and in vitro models: A review 184
Muscarinic cholinergic receptors subtypes in rat cerebellar cortex: light microscope autoradiography of age-related changes 183
Dopamine D4 receptor in human peripheral blood lymphocytes: a radioligand binding assay study 183
Dopamine receptors in human platelets. 182
Effects of stereoisomers of thioctic acid on rat renal vasculature microanatomy 182
Does obesity affect the mucin secretion of the rat intestinal mucosa? 182
Current pharmacological treatments for SARS-COV-2: A narrative review 182
Imidazoline receptors: Qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity 181
Effect of treatment with the cholinesterase inhibitor rivastigmine on vesicular acetylcholine transporter and choline acetyltransferase in rat brain. 180
Effect of choline-containing phospholipids on brain cholinergic transporters in the rat. 180
Totale 25.576
Categoria #
all - tutte 234.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 234.981


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.977 0 0 0 149 257 126 76 216 295 240 222 396
2022/20233.537 456 115 113 418 399 505 55 245 678 226 222 105
2023/20242.984 472 157 196 80 158 234 127 137 390 127 104 802
2024/202510.367 490 292 1.205 789 263 482 930 2.406 709 759 475 1.567
2025/202614.622 742 1.892 995 1.836 1.312 992 2.387 1.230 608 1.045 1.069 514
2026/20274.267 1.100 485 1.616 1.066 0 0 0 0 0 0 0 0
Totale 56.256